FNY Managed Accounts’s Cellectis CLLS Stock Holding History

FNY Managed Accounts’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-7,400	Closed	-$267K	–	443
2015 Q2	$267K	Buy	+7,400	New	+$260K	0.32%	61

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

GLG LLC New York $1.39B AUM 24.01% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

FNY Managed Accounts's CLLS Position: Q3 2015 in Review

FNY Managed Accounts sold out of Cellectis (CLLS) in Q3 2015, closing a stake of 7,400 shares — an estimated $267K sold.

FNY Managed Accounts first reported a position in CLLS in Q2 2015 and held it in 1 quarter. The position peaked at $267K in Q2 2015. 43 funds tracked by Wall St. Rank hold CLLS as of Q3 2015.

FNY Managed Accounts reported no remaining Cellectis position as of Q3 2015 after selling out during the quarter.
FNY Managed Accounts sold 7,400 Cellectis shares in Q3 2015, an estimated $267K.
FNY Managed Accounts first reported a position in Cellectis in Q2 2015 and held it in 1 quarter.
FNY Managed Accounts's Cellectis position peaked at $267K in Q2 2015.
43 funds tracked by Wall St. Rank held Cellectis as of Q3 2015.

Based on FNY Managed Accounts's 13F filing for Q3 2015, filed 27 Oct 2015.